Is COPD in adulthood really so far removed from early development?

European Respiratory Journal

Volumn 35, Issue 1, 2010, Pages 12-13

  Shi, W ^a   Warburton, D ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; DISEASE PREDISPOSITION; EDITORIAL; EMPHYSEMA; GENE EXPRESSION; GENE MUTATION; HUMAN; LUNG FUNCTION; PRIORITY JOURNAL;

ADULT; AGE FACTORS; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 75149160675     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00145809     Document Type: Editorial

References (10)

1. Fletcher C, Peto R. The natural history of chronic airflow obstruction. Br Med J 1977; 1: 1645-1648.
2. Sterner-Kock A, Thorey IS, Koli K, et al. Disruption of the gene encoding the latent transforming growth factor-beta binding protein 4 (LTBP-4) causes abnormal lung development, cardiomyopathy, and colorectal cancer. Genes Dev 2002; 16: 2264-2273.
3. Chen H, Sun J, Buckley S, et al. Abnormal mouse lung alveolarization caused by Smad3 deficiency is a developmental antecedent of centrilobular emphysema. Am J Physiol Lung Cell Mol Physiol 2005; 288: L683-L691.
4. Chen H, Zhuang F, Liu YH, et al. TGF-{beta} receptor II in epithelia versus mesenchyme plays distinct role in developing lung. Eur Respir J 2008; 32: 285-295.
5. Haitchi HM, Powell RM, Shaw TJ, et al. ADAM33 expression in human lungs and asthmatic airways. Am Rev Respir Dis 2005; 171: 958-965.
6. Simpson A, Maniatis M, Jury F, et al. Polymorphisms in a disintegrin and metalloproteinase 33 (ADAM33) predict impaired early lung function. Am Rev Respir Crit Care Med 2005; 172: 55-60.
7. van Diemen CC, Postma DS, Vonk JM, et al. A disintegrin and metalloprotease 33 polymorphisms and lung function decline in the general population. Am J Respir Crit Care Med 2005; 172: 329-333.
8. Gosman MM, Boezen HM, van Diemen CC, et al. A disintegrin and metalloprotease 33 and chronic obstructive pulmonary disease pathophysiology. Thorax 2007; 62: 242-247.
9. Didon L, Roos AB, Elmberger GP, et al. Lung-specific inactivation of CCAAT/enhancer binding protein a causes a pathological pattern characteristic of COPD. Eur Respir J 2010; 35: 186-197.
10. Covar RA, Spahn JD, Murhy JR, et al. Progression of asthma measured by lung function in the childhood asthma amanagment program. Am J Resp Crit Care Med 2004; 170: 206-207.